Valuation: DexCom, Inc.

Market Cap 29.58B 25.85B 23.85B 21.99B 41.44B 2,848B 42.36B 285B 112B 1,395B 111B 109B 4,802B P/E 2026 *
31.3x
P/E 2027 * 26.2x
Enterprise Value 29.15B 25.47B 23.51B 21.67B 40.84B 2,807B 41.74B 281B 111B 1,375B 109B 107B 4,733B EV / Sales 2026 *
5.58x
EV / Sales 2027 * 4.86x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 week+2.15%
Current month+13.61%
1 month+7.99%
3 months+23.54%
6 months+11.59%
Current year+17.21%
1 week 63.3
Extreme 63.3
68.99
1 month 58.66
Extreme 58.66
68.99
3 years 46.85
Extreme 46.85
132
5 years 46.85
Extreme 46.85
144.8
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-1.31%+2.15%-7.79%-45.23% 29.58B
+1.87%+7.19%-16.46%-5.91% 175B
-0.43%-0.80%-7.07%-4.05% 106B
-0.03%+1.47%+4.59%+60.25% 59.91B
+0.66%+0.96%+37.56%+53.38% 51.95B
-1.10%+4.10%-12.56%-38.37% 43.58B
-3.21%-3.05% - - 33.65B
-1.16%+1.28%+61.67%-6.62% 25.31B
-1.49%+0.85%-3.01%-4.60% 21.23B
-0.91%+1.31%-3.73%-18.94% 20.68B
Average -0.64%+1.48%+5.91%-1.12% 59.8B
Weighted average by Cap. +0.15%+2.73%-1.44%+2.34%

Financials

2026 *2027 *
Net sales 5.22B 4.57B 4.21B 3.88B 7.32B 503B 7.48B 50.35B 19.8B 246B 19.62B 19.19B 848B 5.83B 5.09B 4.7B 4.33B 8.16B 561B 8.34B 56.16B 22.09B 275B 21.88B 21.4B 946B
Net income 959M 838M 774M 713M 1.34B 92.4B 1.37B 9.25B 3.64B 45.25B 3.6B 3.52B 156B 1.16B 1.01B 933M 860M 1.62B 111B 1.66B 11.16B 4.39B 54.59B 4.35B 4.25B 188B
Net Debt -429M -375M -346M -319M -601M -41.29B -614M -4.13B -1.63B -20.22B -1.61B -1.57B -69.61B -1.28B -1.12B -1.03B -952M -1.79B -123B -1.83B -12.34B -4.85B -60.4B -4.81B -4.7B -208B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
-
Date Price Change
17/07/26 €67.02 -1.31%
16/07/26 €67.91 +7.10%
15/07/26 €63.41 -2.31%
14/07/26 €64.91 -3.31%
13/07/26 €67.13 +2.32%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
76.65USD
Average target price
85.75USD
Spread / Average Target
+11.87%

Quarterly revenue - Rate of surprise